GlassScriptPhysician profile
Alison Whitman
NPI 1669418067
$16,954.81
in general payments reported to CMS, 2019-2025
55 companies · $2,841 in 2025
The $2,841 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,114 · 2020: $573 · 2021: $3,230 · 2022: $3,019 · 2023: $2,634 · 2024: $2,542 · 2025: $2,841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,880 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,880.45 |
| Education | $136.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,334.01 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Amgen INC. | $1,498.48 | 2019-2025 | Repatha, Otezla, Otezla |
| Lilly USA, LLC | $1,480.29 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $1,441.33 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $893.71 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Janssen Pharmaceuticals, INC | $889.98 | 2019-2024 | Xarelto, Spravato |
| Pfizer INC. | $733.40 | 2019-2025 | |
| Esperion Therapeutics, INC. | $648.51 | 2021-2025 | Nexletol |
| Takeda Pharmaceuticals U.S.A., INC. | $624.30 | 2019-2025 | Trintellix |
| Glaxosmithkline, LLC. | $567.09 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $540.57 | 2019-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $537.55 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $393.82 | 2021-2025 | |
| Astellas Pharma US INC | $358.15 | 2019-2025 | Veozah, Myrbetriq |
| Axsome Therapeutics, INC. | $308.10 | 2022-2025 | Auvelity, Sunosi |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $302.78 | 2019-2024 | Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $292.91 | 2024-2025 | Caplyta |
| Idorsia Pharmaceuticals US INC | $276.28 | 2022-2025 | Quviviq, Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $257.49 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $225.99 | 2019-2025 | Zoryve |
| Lundbeck LLC | $204.58 | 2022-2025 | Vyepti, Rexulti |
| Biohaven Pharmaceuticals, INC. | $174.08 | 2021 | |
| Abbott Laboratories | $173.22 | 2022-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $137.93 | 2019-2023 | |
| Antares Pharma, INC. | $129.83 | 2020-2023 | Xyosted, Nocdurna, Tlando |
| Shield Therapeutics INC | $122.68 | 2023-2024 | Accrufer |
| Sumitomo Pharma America, INC. | $106.75 | 2023-2024 | Gemtesa, Myfembree |
| E.R. Squibb & Sons, L.L.C. | $105.49 | 2022-2025 | Camzyos, Eliquis |
| Bausch Health US, LLC | $100.50 | 2022 | |
| Exact Sciences Corporation | $97.04 | 2023-2025 | Cologuard Collection Kit |
| Clarus Therapeutics INC. | $78.01 | 2021 | |
| Vanda Pharmaceuticals INC. | $71.58 | 2024-2025 | Hetlioz, Fanapt |
| Amarin Pharma, INC. | $69.56 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $66.64 | 2019-2023 | Linzess |
| Verona Pharma, INC. | $66.22 | 2025 | Ohtuvayre |
| Currax Pharmaceuticals LLC | $56.61 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $56.06 | 2019 | |
| Phathom Pharmaceuticals, INC. | $51.98 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $50.58 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $45.15 | 2019-2024 | Ajovy |
| Ardelyx, INC. | $40.21 | 2024-2025 | Ibsrela |
| Allergan, INC. | $39.09 | 2020 | |
| Corcept Therapeutics | $38.00 | 2022-2025 | Korlym |
| Otsuka America Pharmaceutical, INC. | $37.28 | 2023-2025 | Rexulti |
| Upsher-Smith Laboratories LLC | $30.11 | 2022 | |
| Paratek Pharmaceuticals, INC. | $29.69 | 2024 | Nuzyra |
| Horizon Therapeutics Plc | $27.43 | 2021-2022 | |
| Alkermes, INC. | $25.35 | 2025 | Vivitrol |
| Impel Pharmaceuticals INC. | $19.97 | 2022 | |
| Azurity Pharmaceuticals, INC. | $19.65 | 2023 | Horizant |
| Intra-Sana Laboratories | $18.15 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Nestle Healthcare Nutrition INC. | $16.97 | 2021 | |
| Dexcom, INC. | $16.12 | 2024 | Dexcom G6 Transmitter |
| Corium, LLC | $14.87 | 2022 | |
| Sanofi Pasteur INC. | $12.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Whitman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.